National Institute of Allergy and Infectious Disease

Category

UC Irvine Initiates Participation in Worldwide NIAID-Sponsored Adaptive COVID-19 Clinical Trial Assessing Remdesivir (Gilead)

University of California, Irvine (UCI) joins other pathbreaking major academic centers serving as clinical investigative sites nationwide to test Gilead’s remdesivir, the novel antiviral drug developed as a treatment for the Ebola and Marburg virus. With UCI’s...

NIAID Sponsors Phase I Clinical Trial of mAb CIS43LS Targeting Malaria

The National Institute of Allergy and Infectious Diseases (NIAID) has developed a monoclonal antibody (mAb) called mAb CIS43LS targeting malaria. They are now enrolling healthy adult volunteers in a Phase I clinical trial testing the safety and effectiveness of the...

Pin It on Pinterest